Skip to main content

Table 1 Cortactin immunohistochemical detection in 91 HCCs

From: Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma

  Cortactin IHC score P
  0-3 4-6  
Cases (n) 43 48  
Gender 0.846
 Male 33 36  
 Female 10 12  
Mean age (years)a 52.81 ± 1.74 54.46 ± 1.68 0.667
HBsAg 0.265
 (−) 9 15  
 (+) 34 33  
AFP (μg/L)a 276.79 ± 57.33 319.6 ± 61.57 0.614
Liver cirrhosis 0.523
 No 10 14  
 Yes 33 34  
Maximal size (mm)a 6.64 ± 0.84 7.76 ± 0.66 0.531
Liver capsule integrity 0.054
 Complete 34 29  
 Incomplete 9 19  
Tumor nodules (n) 0.084
 Single 34 30  
 Multiple 9 18  
Cancer embolus or metastasis 0.000b
 No 40 21  
 Yes 3 27  
Edmondson classification 0.375
 I-II 21 19  
 III-IV 22 29  
TNM stage (AJCC/UICC) 0.000b
 I-II 32 15  
 III-IV 11 33  
  1. aMean ± SE.
  2. bP <0.01.